Sat.Oct 14, 2023 - Fri.Oct 20, 2023

article thumbnail

Companies Seek To Increase Life Span By A Decade Or More

Forbes: Drug Truths

But keep in mind that it’s going to be a long while before such drugs are actually available.

Drugs 326
article thumbnail

CVS Pulling Popular Cold Meds From Shelves After Report Deems Them to Be Useless

Drugs.com

FRIDAY, Oct. 20, 2023 -- CVS Health plans to pull cold medications that contain phenylephrine from its store shelves after federal regulators determined recently that the decongestant doesn’t work. Oral phenylephrine is an active ingredient.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

With $56M, a Mayo Clinic-backed startup takes aim at radiopharmaceutical roadblocks

BioPharma Drive: Drug Pricing

Nucleus RadioPharma, a contract developer and manufacturer, is expanding at a time when investment is pouring into the radiopharmaceutical drug field.

Drugs 280
article thumbnail

CDD Vault Update (October 2023)

Collaborative Drug

Keyword Searching When using the Keywords search feature in the main Explore Data > Search tab, there is a new “exact” search option available when you select a specific, non-numeric Molecule or Batch field.

278
278
article thumbnail

Bridging Innovation & Patient Care: The Growing Role of AI

Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health

AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!

article thumbnail

Red meat consumption associated with increased type 2 diabetes risk

Science Daily: Pharmacology News

People who eat just two servings of red meat per week may have an increased risk of developing type 2 diabetes compared to people who eat fewer servings, and the risk increases with greater consumption, according to a new study. Researchers also found that replacing red meat with healthy plant-based protein sources, such as nuts and legumes, or modest amounts of dairy foods, was associated with reduced risk of type 2 diabetes.

Research 264

More Trending

article thumbnail

Beam to lay off 100 employees, seek partners in research restructuring

BioPharma Drive: Drug Pricing

The base editing specialist will prioritize medicines for sickle cell and alpha-1 antitrypsin deficiency, while trimming its plans for other programs in cancer and hepatitis B.

Research 273
article thumbnail

Structure-based design of a phosphotyrosine-masked covalent ligand targeting the E3 ligase SOCS2

Covalent Modifiers

Ramachandran, S., Makukhin, N., Haubrich, K. et al. Nat Commun 14, 6345 ( 2023 ). [link] The Src homology 2 (SH2) domain recognizes phosphotyrosine (pY) post translational modifications in partner proteins to trigger downstream signaling. Drug discovery efforts targeting the SH2 domains have long been stymied by the poor drug-like properties of phosphate and its mimetics.

article thumbnail

Ketamine's effect on depression may hinge on hope

Science Daily: Pharmacology News

In an unusual trial, researchers found that a patient's belief that they had received ketamine, even if they didn't, could improve their depression.

Trials 259
article thumbnail

Put These Foods on Your Grocery List for Better Vision

Drugs.com

FRIDAY, Oct. 20, 2023 -- Nutrition is important for your whole body, including those two small organs through which you look at the world. The same diet that’s good for your heart and the rest of your body will also help your eyes, according.

290
290
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

BrainStorm, after setbacks, withdraws approval application for ALS drug

BioPharma Drive: Drug Pricing

A panel of FDA advisers last month found BrainStorm’s data unconvincing. The company now says a Phase 3b study will be needed for its NurOwn cell therapy to have a shot at an approval.

FDA 273
article thumbnail

Defining the Cell Surface Cysteinome using Two-step Enrichment Proteomics

Covalent Modifiers

Tianyang Yan , Lisa Boatner , Liujuan Cui , Peter Tontonoz , Keriann Backus bioRxiv 2023.10.17.562832; doi: [link] The plasma membrane proteome is a rich resource of functional and therapeutically relevant protein targets. Distinguished by high hydrophobicity, heavy glycosylation, disulfide-rich sequences, and low overall abundance, the cell surface proteome remains undersampled in established proteomic pipelines, including our own cysteine chemoproteomics platforms.

147
147
article thumbnail

Generating clean electricity with chicken feathers

Science Daily: Pharmacology News

Turning unused waste from food production into clean energy: Researchers are using chicken feathers to make fuel cells more cost-effective and sustainable.

article thumbnail

In Study, Diabetes Drug Mounjaro Helped Dieters Shed an Average of 60 Pounds

Drugs.com

MONDAY, Oct. 16, 2023 -- A new trial demonstrates the power of the diabetes drug Mounjaro in fighting obesity, helping folks who used the medication lose about 60 pounds. "In this study, people who added tirzepatide [Mounjaro] to diet and exercise.

Drugs 290
article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

Merck cancer drug deal caps pharma investment influx into ‘ADC’ field

BioPharma Drive: Drug Pricing

With the alliance, Merck joins Pfizer, AstraZeneca and Gilead in staking major bets on the potential for antibody-drug conjugates to reshape cancer treatment.

Drugs 264
article thumbnail

Ultra-rapid Electrophilic Cysteine Arylation [@WangGroupURICHM]

Covalent Modifiers

Bradley M. Lipka, Daniel S. Honeycutt, Gregory M. Bassett, Taylor N. Kowal, Max Adamczyk, Zachary C. Cartnick, Vincent M. Betti, Jacob M. Goldberg, and Fang Wang Journal of the American Chemical Society 2023 DOI: 10.1021/jacs.3c10334 Rapid bond-forming reactions are crucial for efficient bioconjugation. We describe a simple and practical strategy for facilitating ultra-rapid electrophilic cysteine arylation.

147
147
article thumbnail

Molecular age of the eye determined

Science Daily: Pharmacology News

A team of researchers have mapped almost 6,000 proteins from different cell types within the eye by analyzing tiny drops of eye fluid that are routinely removed during surgery. The researchers used an AI model to create a 'proteomic clock' from this data that can predict a healthy person's age based on their protein profile. The clock revealed that diseases such as diabetic retinopathy and uveitis cause accelerated aging within specific cell types.

Disease 253
article thumbnail

Amazon to Test Drones to Deliver Prescriptions to Your Door

Drugs.com

THURSDAY, Oct. 19, 2023 -- Soon, you may be able to step out on your front porch and wait for your prescription medication to drop from the sky. On Wednesday, Amazon Pharmacy announced that it is starting to test speedy prescription drug delivery.

Pharmacy 279
article thumbnail

Deliver Fast, Flexible Clinical Trial Insights with Spotfire

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.

article thumbnail

Ultragenyx to spin out new company around Alzheimer’s gene therapy

BioPharma Drive: Drug Pricing

CEO Emil Kakkis says the company's findings are too exciting to ignore, but the “high-risk, high-return” venture needs to be pursued outside the organization.

Therapies 265
article thumbnail

Drug Discovery Industry Roundup with Barry Bunin — October 17, 2023

Collaborative Drug

Drug Discovery Industry Roundup with Barry Bunin — October 17, 2023

Drugs 130
article thumbnail

Wearable device makes memories and powers up with the flex of a finger

Science Daily: Pharmacology News

Researchers have invented an experimental wearable device that generates power from a user's bending finger and can create and store memories, in a promising step towards health monitoring and other technologies.

Research 247
article thumbnail

Living Alone Raises Americans' Cancer Risk by Nearly a Third

Drugs.com

THURSDAY, Oct. 19, 2023 -- People who live alone have a greater risk of dying from cancer, a new study warns. Researchers from the American Cancer Society showed that U.S. adults who live alone had a 32% higher risk of cancer death than those who.

Research 278
article thumbnail

Clinical Data Like You´ve Never Seen It Before: Why Spotfire Is the Leading Tool for Clinical Analytics

Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic

article thumbnail

The top biopharma conferences in 2024

BioPharma Drive: Drug Pricing

A few key meetings remain this year, like ESMO and ASH, while next year’s events are already being planned. Here’s a list of conferences to keep in mind.

264
264
article thumbnail

Health Literacy Month: How industry communication can impact patient health literacy

Antidote

Since 1999, October has been designated as Health Literacy Month , a month dedicated to promoting patient-centricity in healthcare communications across the industry. Health literacy refers to a person’s ability to find, understand, and use health-related services and make informed decisions for themselves and others.

122
122
article thumbnail

Black holes could come in 'perfect pairs' in an ever expanding Universe

Science Daily: Pharmacology News

Researchers have shown it's theoretically possible for black holes to exist in perfectly balanced pairs -- held in equilibrium by a cosmological force -- mimicking a single black hole.

Research 246
article thumbnail

Olympian Mary Lou Retton Suffers Setback in Battle With Rare Form of Pneumonia

Drugs.com

THURSDAY, Oct. 19, 2023 -- Former Olympic gymnast Mary Lou Retton has suffered a "scary setback" as she fights a rare type of pneumonia while in the intensive care unit of a hospital, her family said Wednesday. The 55-year-old, who lives in the.

Hospitals 278
article thumbnail

Novo’s Uli Stilz on biotech innovation and the future of diabetes drugs

BioPharma Drive: Drug Pricing

The Danish drugmaker's innovation hub in Boston has teamed up with the Broad Institute, Mass General Brigham, Harvard and Yale, expanding its research into cardiometabolic diseases.

Disease 177